$WPC

Friedenthal Financial Acquires Shares of 14,504 W.P. Carey Inc. $WPC

Friedenthal Financial recently acquired a new position in W.P. Carey Inc. (NYSE:WPC), purchasing 14,504 shares valued at approximately $933,000 during the 4th quarter. Several other institutional investors also adjusted their holdings in the real estate investment trust. Wall Street analysts maintain a consensus "Hold" rating on WPC with an average target price of $71.90.

Original reporting
MarketBeat · MarketBeat
Published Apr 19, 2026, 12:28 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Apr 19, 2026, 1:00 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
Friedenthal Financial Acquires Shares of 14,504 W.P. Carey Inc. $WPC — source image
Decision brief

The 30-second read

$WPCNeutralLow
01

Why it matters

While the purchase is positive, the overall analyst sentiment remains cautious, suggesting limited immediate trading impact.

02

Market read

The news signals some institutional confidence but does not drastically alter the current market outlook for WPC.

03

What to watch

Broader economic conditions and interest rate trends could offset positive institutional activity.

Timing: short-term

Background

Friedenthal Financial's recent purchase indicates institutional interest, possibly reflecting confidence in W.P. Carey Inc.'s long-term prospects.

Company-level read

Ticker impact

$WPCNeutralMedium confidence
Context

Recent institutional purchase and maintained hold rating suggest moderate positive sentiment.

Expected impact

Minor upward price movement (~1-2%) over the next 1-2 weeks.

Evidence & confidence

Institutional purchase of 14,504 shares valued at approximately $933,000 signals some confidence, but analyst consensus remains neutral with a target price close to current valuation, suggesting limited immediate impact.

Market effects

Reinforces stability in the real estate investment trust (REIT) sector.

Limited regional impact; primarily relevant to US markets.

Minimal global market relevance given sector-specific nature.

Counterpoint

Institutional buying might be a strategic move for long-term accumulation rather than short-term price influence.

Key entities

  • Friedenthal Financial

    A financial firm acquiring shares in W.P. Carey Inc.

  • W.P. Carey Inc.

    A real estate investment trust with a focus on commercial properties.

Related articles

$MAAMed

Mid-America Apartment Communities Vs. W.P. Carey: Why One REIT Dividend Claimed 86% Of Core AFFO - W.P.

Mid-America Apartment Communities (MAA) reported Q2 Core AFFO of $1.77 per share, down from $1.85, and kept its quarterly dividend at $1.530. It narrowed full-year Core AFFO guidance to $7.38–$7.62 and said new-lease pricing fell 5.3%. W. P. Carey (WPC) reported Q2 AFFO of $1.34, raised its dividend to $0.940, and lifted/narrowed full-year AFFO guidance to $5.19–$5.27.

$WPCMed

W. P. Carey Inc. (WPC): Results of Operations and Financial Condition

W. P. Carey Inc. (WPC) filed an SEC Form 8-K — Results of Operations and Financial Condition. EX-99.2 3 wpc2026q2supplementalexh992.htm EX-99.2 Document Exhibit 99.2 W. P. Carey Inc. Supplemental Information Second Quarter 2026 Terms and Definitions As used in this supplemental package, the terms “W. P. Carey,” “WPC,” “we,” “us” and “our” include W. P. Carey Inc., its con

Med

Carey Gillam on the Supreme Court’s Decision in the Roundup Case

The US Supreme Court, in a 7-2 ruling in Monsanto v. Durnell, sided with Monsanto, now Bayer, holding that failure-to-warn claims are preempted when the EPA did not require a cancer warning for the pesticide. The decision is expected to limit Roundup-related cancer lawsuits. The article cites Bayer stock up 17% and says Bayer has paid over $11B and is offering $7.25B for class action settlement.

$MSFTHigh

Prediction: Microsoft Could Be the Next $5 Trillion Stock

Microsoft (MSFT) received a BUY rating and $600 price target from 24/7 Wall St., citing 43% Azure growth and a $678B commercial RPO backlog. The stock is up 27.81% over the past month and 3.29% year-to-date, with Q4 FY26 revenue of $90.01B and non-GAAP EPS of $4.74. The target implies 18.9% upside, potentially pushing market cap to $5T. Bulls highlight demand outpacing supply, while bears note capital intensity and declining PC revenue.

$LLYMedAI 9/10

FRI AM News: WisBusiness: the Podcast with Serafino Fabiano, Eli Lilly and Company; State joins lawsuit targeting Trump administration over family planning funding

Eli Lilly and Company's Kenosha facility, acquired in 2024, is part of a $4 billion investment in Wisconsin for injectable medicine production. The site, which received FDA approval in 18 months, is producing drugs like Zepbound and Mounjaro. The facility is expected to support 750 jobs and has attracted attention due to its strategic location and skilled workforce. Wisconsin has also joined a lawsuit against the Trump administration's family planning funding rules. The state collected $450.8 mi

$EXCMed

Why Exelon's CFO is stepping into a new strategy role

Exelon's CFO Jeanne Jones transitions to a new role as EVP of finance and strategy on Oct. 5, focusing on long-term strategy and capital allocation. Robert Kleczynski will succeed Jones as CFO. Exelon reported Q2 revenue of $5.97 billion, up 10% YoY, beating estimates. The company is investing in infrastructure amid rising electricity demand and pressure to keep customer bills affordable.